Kaplan–Meier survival curves revealed that the prognosis of patients with ccRCC with high RUNX1 expression was worse than that of patients with ccRCC with low RUNX1 expression (p < 0.001). This evidence concerns the gene RUNX1 and nonpapillary renal cell carcinoma.